Pharmaleaders TV

Breaking News

ticket title
The remarkable recovery of a Sundarbans’ resident from a devastating tiger attack
Hearzap Strengthens Market Position with 51% Acquisition of Speech and Hearing Care
Fischer Medical Ventures Ltd Partners with Bio Angle Vacs Sdn Bhd’s in Science, Technology and Marketing to bring their Breakthrough Vaccine Products
India Leadership Conclave 2024 Power Brand Awards conferred to top Business Leaders
Healthcare Innovation in India to Double, $60 Billion Opportunity by 2028 Pharma services and healthtech account for 80% of the market,Biotech and Medtech emerge as greenshoots
1 in 5 people diagnosed with diabetes in the last 5 years are in the age group 18-30 years
Remedium Lifecare Limited bags “Best Returns to the Investors Award” at Brandscouncil Ratings & Medilinks India Awards 2023
Largest kidney stone removed using a new-minimally invasive Holmium laser with Moses 2.0 technology
A Comprehensive Analysis of Spirulina’s Nutritional Value, Industrial Applications, and Market Potential
Dr. Reddy’s opts for AWS as preferred cloud provider to develop affordable pharma therapies for patients worldwide
You are here:  / Indian News / The prices of the 348 drugs included in the national list of essential medicines are to be fixed under the new drug policy that came into force last year

The prices of the 348 drugs included in the national list of essential medicines are to be fixed under the new drug policy that came into force last year

The prices of the 348 drugs included in the national list of essential medicines are to be fixed under the new drug policy that came into force last year

PHARMALEADERS

Pharmaleaders is India’s first opinion based & research driven bi-monthly magazine & has a decade of relentless reporting in Pharma Journalism in an unbiased, fearless & independent way. Over the last one decade, The Magazine has covered some of the biggest voices in the healthcare Industry. Available both in digital & printed format, Pharmaleaders has emerged out as a leading title in voicing the opinion of the healthcare industry.

RELATED ARTICLES

The remarkable recovery of a Sundarbans’ resident from a devastating tiger attack

The remarkable recovery of a Sundarbans’ resident from a devastating tiger attack

12  0
AiMeD hails Union Budget-2024; will give a boost to overall economic growth: Rajiv Nath

AiMeD hails Union Budget-2024; will give a boost to overall economic growth: Rajiv Nath

9  0
Narsi Kularia hands over the Primary Healthcare Centre to Rajasthan government in Nokha

Narsi Kularia hands over the Primary Healthcare Centre to Rajasthan government in Nokha

20  0
Healthcare Innovation in India to Double, $60 Billion Opportunity by 2028 Pharma services and healthtech account for 80% of the market,Biotech and Medtech emerge as greenshoots

Healthcare Innovation in India to Double, $60 Billion Opportunity by 2028 Pharma services and healthtech account for 80% of the market,Biotech and Medtech emerge as greenshoots

59  0

The remarkable recovery of a Sundarbans’ resident from a devastating tiger attack

Business

The remarkable recovery of a Sundarbans’ resident from a devastating tiger attack

read more
Hearzap Strengthens Market Position with 51% Acquisition of Speech and Hearing Care

Business

Hearzap Strengthens Market Position with 51% Acquisition of Speech and Hearing Care

read more
Fischer Medical Ventures Ltd Partners with Bio Angle Vacs Sdn Bhd’s in Science, Technology and Marketing to bring their Breakthrough Vaccine Products

Business

Fischer Medical Ventures Ltd Partners with Bio Angle Vacs Sdn Bhd’s in Science, Technology and Marketing to bring their Breakthrough Vaccine Products

read more
1 in 5 people diagnosed with diabetes in the last 5 years are in the age group 18-30 years

Business

1 in 5 people diagnosed with diabetes in the last 5 years are in the age group 18-30 years

read more
Remedium Lifecare Limited bags “Best Returns to the Investors Award” at Brandscouncil Ratings & Medilinks India Awards 2023

Business

Remedium Lifecare Limited bags “Best Returns to the Investors Award” at Brandscouncil Ratings & Medilinks India Awards 2023

read more
Follow us
Contact us

Network 7 Meadia Group

Plot 5, NS Road No. 12, JVPD, Juhu Scheme, Mumbai, Maharashtra 400049. editorial@pharmaleaders.tv